Benitec Biopharma (BNTC) Return on Sales (2019 - 2024)
Benitec Biopharma (BNTC) reported Return on Sales of 568.99% for Q1 2024, down 56791.0% on a YoY basis from N/an in Q2 2023, and down 7331.21% sequentially from 7.66% in Q4 2023.
Benitec Biopharma (BNTC) Return on Sales (2019 - 2024) Analysis & Trends
Benitec Biopharma (BNTC) has 6 years of Return on Sales data on file, last reported at 568.99% in Q1 2024.
- For the quarter ending Q1 2024, Return on Sales fell 56791.0% year-over-year to 568.99%; the trailing twelve-month figure through Mar 2024 stood at 568.99% (down 56307.0% YoY), and the FY2023 full-year result was 4.13%, up 78.0% from the prior year.
- Return on Sales slipped to 568.99% in Q1 2024, from 7.66% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 4.62% in Q2 2020 to a low of 568.99% in Q1 2024.
- A 5-year average of 44.41% and a median of 4.98% in 2022 frame the typical range for Return on Sales.
- Across the five-year window, Return on Sales surged 3726 bps in 2022 and slumped 56791 bps in 2024, its largest moves.
- Tracing BNTC's Return on Sales over 5 years: stood at 35.82% in 2020, then soared by 94 bps to 1.99% in 2021, then plunged by 127 bps to 4.53% in 2022, then tumbled by 69 bps to 7.66% in 2023, then plunged by 7331 bps to 568.99% in 2024.
- Business Quant data shows BNTC's Return on Sales at 568.99% in Q1 2024, 7.66% in Q4 2023, and 4.64% in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -568.99% |
| Dec 31, 2023 | -7.66% |
| Sep 30, 2023 | -4.64% |
| Jun 30, 2023 | -23.48% |
| Mar 31, 2023 | -1.08% |
| Dec 31, 2022 | -4.53% |
| Sep 30, 2022 | -5.02% |
| Jun 30, 2022 | -4.98% |
| Mar 31, 2022 | -0.75% |
| Dec 31, 2021 | -1.99% |
| Sep 30, 2021 | -41.20% |
| Jun 30, 2021 | -20.24% |
| Mar 31, 2021 | -38.01% |
| Dec 31, 2020 | -35.82% |
| Sep 30, 2020 | -0.49% |
| Jun 30, 2020 | 4.62% |
| Mar 31, 2020 | -0.75% |
| Dec 31, 2019 | -0.27% |
| Sep 30, 2019 | -0.35% |